NVST · XBRL financial data

Envista Holdings financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (NVST's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	2,282	2,509	2,569	2,567	—	—
Revenue from contracts with customers	2,282	2,509	2,569	2,567	2,511	2,720
Cost of goods and services sold	1,124	1,082	1,094	1,126	1,138	1,233
Gross profit	1,158	1,427	1,475	1,441	1,373	1,487
Research and development	101	101	100	94	99	114
Selling, general and administrative	1,024	1,020	1,056	1,057	1,158	1,157
Total operating expenses	—	—	2,128	2,178	2,268	—
Operating income (loss)	33	306	319	32	(1,038)	216
Interest expense	63	54	38	63	—	—
Other income (expense)	(1)	2	3	(23)	(0)	(2)
Income tax expense (benefit)	(63)	(9)	46	45	34	130
Net income (loss)	33	341	243	(100)	(1,119)	47
Earnings per share, basic USD per share	0.21	2.11	1.49	(0.60)	(6.50)	0.28
Earnings per share, diluted USD per share	0.20	1.92	1.37	(0.60)	(6.50)	0.28
Weighted average shares, basic millions of shares	160	161	163	167	172	168
Weighted average shares, diluted millions of shares	164	178	178	167	172	169

Fiscal years (NVST's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	889	1,074	607	940	1,069	1,212
Accounts receivable	361	332	394	408	363	430
Inventory	267	264	301	259	241	288
Prepaid and other current assets	74	154	123	137	115	97
Total current assets	1,591	1,836	1,425	1,744	1,788	2,027
Property and equipment, net	303	264	294	310	277	297
Right-of-use asset	165	128	132	125	143	142
Goodwill	3,431	3,132	3,497	3,292	2,262	2,358
Total assets	6,876	6,574	6,587	6,605	5,351	5,679
Total current liabilities	1,685	1,208	1,237	781	879	853
Long-term debt	908	883	871	1,398	1,278	1,448
Lease liability, non-current	154	120	121	110	119	110
Retained earnings (accumulated deficit)	126	467	731	631	(487)	(440)
Total stockholders' equity	3,721	4,058	4,207	4,174	2,935	3,106
Total liabilities and equity	6,876	6,574	6,587	6,605	5,351	5,679
Common shares outstanding (cover page) millions of shares	160	162	163	172	172	164

Fiscal years (NVST's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	33	341	243	(100)	(1,119)	47
Stock-based compensation	23	28	31	31	35	38
Depreciation and amortization	133	118	138	136	123	116
Net cash from operating activities	284	362	183	276	337	276
Purchases of property and equipment	48	55	76	58	34	45
Net cash from investing activities	(69)	263	(657)	(62)	(55)	(51)
Proceeds from issuing common stock	0	0	—	—	—	—
Net cash from financing activities	493	(466)	13	119	(104)	(171)
Net change in cash	678	185	(467)	333	129	143

SIC 3843 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3843 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Envista Holdings	1,126	731	119*	160.6M	—	Q2 FY26 10-QJul 3, 2026
LivaNova	517	391	67*	55.1M	—	Q2 FY26 10-QJun 30, 2026
Teleflex	300	570	not reported	42.4M	—	Q2 FY26 10-QJun 30, 2026
Haemonetics	223	339	52	45.5M	—	Q1 FY27 10-QJun 27, 2026
MiniMed Group	207	843	(49)	281.3M	2.3 quarters	Q1 FY27 10-QJul 31, 2026
Dentsply Sirona	239	898	99*	199.4M	—	Q2 FY26 10-QJun 30, 2026
PROCEPT BioRobotics	228	94	(19)*	57.3M	11.8 quarters	Q2 FY26 10-QJun 30, 2026
Icu Medical	298	552	80*	25.0M	—	Q2 FY26 10-QJun 30, 2026
Enovis	13	583	75*	57.7M	—	Q2 FY26 10-QJul 3, 2026

Not investment advice. Not affiliated with the U.S. SEC.